TITLE

One Biotech's Cross-Border Deal

AUTHOR(S)
Abrams, Sandra Lea
PUB. DATE
October 2004
SOURCE
Investment Dealers' Digest;10/25/2004, Vol. 70 Issue 41, p28
SOURCE TYPE
Trade Publication
DOC. TYPE
Interview
ABSTRACT
Interviews Mirko Scherer, CFO of Munich, Germany-based biotechnology company, GPC Biotech AG, about the company's decision to reach out to a new group of investors and how it selected its bankers in the U.S. Factors used in choosing the firms; Outlook towards the differences between working with European and American bankers; Plans for the financial health of the company.
ACCESSION #
14809208

 

Related Articles

  • German Industry Beefs Up. Gopal, Kevin // Pharmaceutical Executive;Jun2001, Vol. 21 Issue 6, p32 

    Focuses on the growth of the biotechnology industry in Germany. Factors contributing to the industry's progress; Information on MediGene and GPC Biotech, beneficiaries of equity funding in the country; Overview of MediGene's products in development. INSET: Helping Hands.

  • Agennix Completes GPC Merger, but Badly Needs Cash Infusion. Moran, Nuala // BioWorld International;11/11/2009, Vol. 14 Issue 45, p1 

    The article reports on the merger between Agennix AG and GPC Biotech AG. Following the completion of the merger, Agennix launched its lead product, talactoferrin, in two ongoing U.S. Phase III trials. Under the merger, shareholders of GPC Biotech received one share of Agennix for every five...

  • OTHER NEWS TO NOTE.  // BioWorld Today;3/16/2009, Vol. 20 Issue 49, p2 

    This section offers news briefs on the biotechnology industry in the U.S. and Canada. Results of a commercial beef feedlot study using the Escherichia coli 015 vaccine has been reported by Bioniche Life Sciences Inc. A letter has been sent by Biotechnology Value Fund LP to the stockholders of...

  • GPC Biotech and Agennix to merge.  // PharmaWatch: Biotechnology;Apr2009, Vol. 8 Issue 4, p22 

    The article reports on the merger of Germany-based GPC Biotech AG and U.S.-based biotechnology company Agennix Inc. It is noted that the merger combines GPC Biotech AG's and Agennix Inc.'s oncology pipelines. The merged company will focus on the development of new anti-cancer therapies....

  • GPC Cuts Staff 44 Percent To Conserve Operating Cash. Osborne, Randall // BioWorld International;11/21/2007, Vol. 12 Issue 47, p2 

    The article reports on the decision of GPC Biotech AG to cut its workforce to conserve operating cash. Laurie Doyle, director of investor relations and corporate communications, said that the effort of GPC to explore merger and acquisition chances on both sides of the Atlantic is a very...

  • OTHER NEWS TO NOTE.  // BioWorld International;3/18/2009, Vol. 14 Issue 11, p2 

    This section offers news briefs related to the biotechnology industries. Astellas Pharma Inc. has decided to terminate its $16 per share acquisition offer for CV Therapeutics Inc. The U.S. District Court for the Southern District of New York dismissed a class-action lawsuit against GPC Biotech...

  • Biotechnology in Germany.  // Biotechnology Industry Profile: Germany;January 2003, pN.PAG 

    Presents a profile of the Biotechnology industry in Germany. Executive summary of the industry; Market overview; Market value; Market segmentation; Competitive landscape; Leading companies in the industry; Market forecasts; Demographics; Further reading.

  • Biotechnology in Germany.  // Biotechnology Industry Profile: Germany;November 2004, p1 

    Presents a profile of the Biotechnology industry in Germany. Executive summary of the industry; Market overview; Market value; Market segmentation; Competitive landscape; Leading companies in the industry; Market forecasts; Demographics; Further reading.

  • GPC Biotech cuts 15% of staff.  // PharmaWatch: Biotechnology;Oct2007, Vol. 6 Issue 10, p20 

    The article reports on the restructuring plan of GPC Biotech AG that involves the reduction of about 15 percent of its total workforce in the U.S. Bernd Seizinger, chief executive officer (CEO), extends his sincere appreciation to the affected employees for their services. The company also plans...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics